U.S. companies are removing their CEOs at the fastest clip in two decades, data shows, as increased scrutiny from ...

U.S. companies are removing their CEOs at the fastest clip in two decades, data shows, as increased scrutiny from ...

Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...

Investors own more than half of all the houses in seven California counties. That’s one eye-catching nugget from my trusty spreadsheet’s review of data on investor activity across the nation ...

Kenvue, which was spun off from Johnson & Johnson in 2023, has been working to shore up profitability, especially in its struggling skin health and beauty unit which includes brands like Neutrogena ...

BAND-AID and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the ...

We recently published 10 Stocks Jim Cramer Discussed As He Commented On Latest Tariffs. Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer recently discussed.

Among the suitors are the billionaire telecom moguls Martin Bouygues and Iliad-owner Xavier Niel. Orange is also hoping for a slice of the pie, but France’s largest telecom would face significant ...

Kenvue says that Thibaut Mongon is leaving as CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part of Johnson & Johnson.

Find the answer for Civil Rights activist Garvey from the people who brought you the USA TODAY Daily Crossword Puzzle.